Pressure and inspiratory flow characteristics of dry powder inhalers.

Respir Med

Institut für Pneumologie, Allergologie und Schlafmedizin am Herz-Jesu-Krankenhaus, D56428 Dernbach, Germany.

Published: April 2004

This study compared inspiratory characteristics of the Novolizer and Turbuhaler. Sixty patients with obstructive lung disease (40 asthmatics, 20 patients with COPD) and without DPI experience were enrolled into this investigator initiated, randomized, cross-over study. Collected data of 56 patients were eligible for analysis. Inspiratory pressure and inspiratory flow through both devices were measured in every patient using a double-beam oscilloscope. Peak inspiratory flow (PIF), duration of inspiratory flow > 60 l/min and increase in inspiratory pressure were significantly higher in the Novolizer group. In addition, the inspiratory flow rate 0.1 s after beginning of inhalation was over two-times higher at inhalation through the Novolizer compared to inhalation through the Turbuhaler. The Turbuhaler data, but not the Novolizer data, showed a significant negative correlation between lung function and inspiratory flow. The dynamic resistance of the Turbuhaler was 5.5-times higher than that of the Novolizer. Patients using the Turbuhaler had to invest a significantly higher inspiratory effort compared to the use of the Novolizer in order to achieve the same inspiratory flow (e.g., 60 l/min). Indeed, more than 40% of the patients in the Turbuhaler group failed to reach an inspiratory flow of 60 l/min. Overall, patients inhaling through the Novolizer had a better inhalation performance than those inhaling through the Turbuhaler.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.rmed.2004.02.003DOI Listing

Publication Analysis

Top Keywords

inspiratory flow
32
flow l/min
12
inspiratory
11
pressure inspiratory
8
flow
8
inspiratory pressure
8
higher novolizer
8
patients turbuhaler
8
novolizer
7
turbuhaler
7

Similar Publications

Introduction: Patients recovering from severe acute exacerbations of chronic obstructive pulmonary disease (AECOPD) have a 30-day readmission rate of 20%. This study evaluated the feasibility of conducting a randomised controlled trial to evaluate clinical, patient-reported and physiological effects of home high-flow therapy (HFT) in addition to usual medical therapy, in eucapnic patients recovering from AECOPD to support the design of a phase 3 trial.

Methods: A mixed-methods feasibility randomised controlled trial (quantitative primacy, concurrently embedded qualitative evaluation) (ISRCTN15949009) recruiting consecutive non-obese patients hospitalised with AECOPD not requiring acute non-invasive ventilation.

View Article and Find Full Text PDF
Article Synopsis
  • Observational studies show that using high-flow nasal cannula (HFNC) from 2013-2016 is linked to longer oxygen therapy duration, increased rates of bronchopulmonary dysplasia (BPD), and retinopathy of prematurity (ROP).
  • The study aimed to analyze neonatal outcomes for very preterm newborns with HFNC between 2017-2021, using statistical methods to compare cases with controls based on weight and gestational age.
  • Results indicated a significant rise in BPD and ROP in the HFNC group, alongside higher respiratory support, with logistic regression confirming HFNC use is associated with greater risks for both conditions, suggesting the need for a quality improvement program to enhance HFNC
View Article and Find Full Text PDF

High flow nasal cannula (HFNC) can reduce the need for intubation in patients with coronavirus disease-19 (COVID-19) pneumonia induced acute hypoxemic respiratory failure (AHRF), but predictors of HFNC success could be characterized better. C-reactive protein (CRP) and D-dimer are associated with COVID-19 severity and progression. However, no one has evaluated the use of serial CRP and D-dimer ratios to predict HFNC success.

View Article and Find Full Text PDF

Introduction: Preclinical studies have shown that oxygen therapy can improve ischaemic brain tissue oxygen tension, reduce reperfusion injury after revascularisation, promote neuroregeneration and inhibit inflammatory responses potentially exerting a beneficial effect after endovascular treatment (EVT) in patients with acute ischaemic stroke (AIS). However, the optimal fraction of inspired oxygen (FiO) during EVT under general anaesthesia is currently unknown. Therefore, we are conducting a randomised controlled trial (RCT) to evaluate the impact of high-concentration oxygen vs low-concentration normobaric oxygen on early neurological function after EVT.

View Article and Find Full Text PDF

This cross-sectional study aimed to investigate the role of peak inspiratory flow rate (PIFR) in the management of inhalation therapy for patients with chronic obstructive pulmonary disease (COPD). Conducted in the Department of Pulmonary Medicine at a tertiary care institute from July 2021 to January 2022, this study included a total of 351 patients who were clinically diagnosed with stable COPD and currently receiving inhaler therapy. Participants underwent comprehensive assessments that included demographic data collection, the use of the ABCD assessment tool to evaluate disease severity, the COPD Assessment Test (CAT) for quality of life measurement, and assessments for adherence to inhaler therapy and inhaler technique proficiency.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!